Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Summary

Experimental autoimmune encephalomyelitis (EAE) is an animal model of multiple sclerosis (MS), which shares with the human disease a robust humoral autoimmune response. Here, we report a simple and flexible ELISA protocol to quantify autoantibodies in the serum of EAE immunized mice.

Abstract

Experimental autoimmune encephalomyelitis (EAE) is a disease model that recapitulates the autoimmune disorder multiple sclerosis (MS) at histopathological and molecular levels. EAE is induced by immunizing experimental animals via subcutaneous injection of short myelin peptides together with specific adjuvants to boost the immune response. Like the human counterpart, EAE mice develop demyelinating lesions, immune cell infiltration into the central nervous system (CNS), glia activation and neuronal injury. A consistent body of evidence also supports a mechanistic role for B cell dysfunction in the etiology of both MS and EAE. B cells can serve as antigen-presenting cells as well as a primary source of pro-inflammatory cytokines and autoantibodies. In EAE, antibodies are generated against the myelin peptides that were employed to induce the disease. Such autoantibodies have been shown to mediate either myelin loss or pathogenic T cell reactivation into the CNS. This article describes an efficient ELISA-based protocol to quantify autoantibodies in the serum of C57BL/6J mice immunized with the myelin oligodendrocyte glycoprotein 35-55 (MOG35-55) peptide. The proposed method serves as a powerful tool to investigate the specificity and magnitude of the aberrant humoral response in the context of autoimmune demyelination.

Introduction

Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) characterized by focal infiltration of immune cells into the brain parenchyma, breakdown of myelin sheaths wrapping axons, glia activation, and neuronal loss¹. In addition to the well-established role of pathogenic T cells, multiple lines of evidence have highlighted the involvement of B cells in mediating the autoimmune response against the CNS. B cells undergo clonal expansion in the MS brain and antibodies against myelin components have been detected within demyelinated lesions^2,3. The selective activation of peripheral B cells at disease onset has been recently documented, suggesting a putative role for this immune cell compartment in disease initiation as well⁴. The success of B cell-depleting therapies such as anti-CD20 monoclonal antibodies further corroborates the mechanistic connection between aberrant B cell functioning and autoimmune demyelination^5,6. From a molecular standpoint, B cells can contribute to disease via autoantigen presentation, pro-inflammatory cytokine secretion, and autoreactive antibody production.

Multiple animal models have been developed to recapitulate specific features of the complex MS phenotype. Among them, experimental autoimmune encephalomyelitis (EAE) is the most widely used in vivo paradigm and relies on the immunization of experimental animals with short peptides derived from myelin proteins such as myelin oligodendrocyte glycoprotein (MOG) and myelin basic protein (MBP)⁷. EAE immunized animals develop a demyelinating pathology that resembles MS in many aspects, including a robust humoral response against the encephalitogenic peptide⁸. For this reason, EAE studies have been instrumental in dissecting the function of B cells and autoantibodies in the context of disease. For instance, it was demonstrated that MOG-specific antibodies isolated from MS patients can aggravate the clinical course in EAE models⁹. Notably, the proline residue at position 42 in human MOG was shown to be critical for determining autoantibody pathogenicity¹⁰. More recently, MOG-specific autoantibodies have been found to promote disease not only by mediating myelin loss but also via boosting the reactivation of autoreactive T cells within the CNS¹¹.

Considering the importance of antibody responses in CNS autoimmunity, this article presents an ELISA-based protocol to efficiently measure the serum levels of autoreactive antibodies in C57BL/6J mice EAE immunized with MOG35-55 peptide. In the first part of the protocol, the method to collect serum via intracardiac puncture will be described. Subsequently, the procedures to set up the ELISA assay and acquire the data will be detailed. Lastly, data analysis and interpretation will be discussed.

Protocol

All procedures involving mice were performed in compliance with experimental guidelines approved by the East Carolina University Institutional Animal Care and Use Committee (IACUC). Wildtype C57BL/6J female mice between 8-10 weeks of age were used in this study. The animals were obtained from a commercial source (see Table of Materials). EAE was induced following previously published reports^12,13,14.

1. Serum collection

1. Euthanize the experimental mouse by CO₂ asphyxiation or isoflurane overdose at the required time point (following institutionally approved protocols) after inducing EAE via MOG35-55 immunization.
   NOTE: The total number of mice and time points for serum collection can vary according to the specific experiment.
2. After the absence of vital signs is confirmed by toe or tail pinch, place the mouse in a dorsal recumbency position on a dissection tray and affix the limbs in position with pins or tape. Orient the mouse body to the LED light source (see Table of Materials) to illuminate the thorax of the animal.
3. Spray the mouse fur with 70% ethanol and make a midline incision of 3-4 cm along the abdomen from the pelvis to the xiphoid using the dissector scissors, taking care to avoid any organs and major vessels (Figure 1A-C). To facilitate the procedure, use the forceps to grab the skin over the xiphoid process.
4. Cut through the diaphragm laterally and then cut the rib cage anteriorly on both lateral edges using the spring scissors, stopping before reaching the sternum at the midline (Figure 1D). Fold the rib flap that was created over the mouse head to expose the heart (Figure 1E).
   NOTE: Cutting the sternum should be avoided as this will damage the main thoracic arteries laying adjacent to the bone and reduce the volume of blood that can be collected.
5. Insert a 25 G needle connected to a 1 mL syringe into the left ventricle and collect the blood by gently pulling back the plunger (Figure 1F). To facilitate the needle puncture, gently brace the heart against a pair of forceps.
   NOTE: If the blood does not appear immediately into the syringe, the needle should be slowly rotated, and a different angle should be tested. However, efforts should be made to place the needle properly on the first attempt to avoid creating unnecessary holes in the heart where blood can leak out.
6. Transfer the blood into a sterile 1.5 mL tube and allow it to clot for 30 min at room temperature. Remove the clot by centrifugation at 2000 × g for 20 min at 4 °C. Collect the supernatant, which represents the serum fraction, and store single-use aliquots into cryogenic tubes at -80 °C for future testing.

2. ELISA assay

1. Resuspend the lyophilized MOG35-55 peptide (see Table of Materials) in water to obtain a 10 mg/mL stock. Before starting the experiment, dilute the stock to 10 μg/mL in coating buffer (see Table of Materials) and pipette 100 μL/well of the final solution into a 96-well plate. Seal the plate with an adhesive film to avoid evaporation and incubate the plate overnight at 4 °C.
   NOTE: At least 2 wells should be calculated for each sample and 2 additional wells should be also included for a blank control.
2. In parallel, coat the same number of wells with 100 μL/well of bovine serum albumin (BSA) dissolved in coating buffer at 10 μg/mL concentration. These additional wells will serve as background controls.
   NOTE: It is recommended to coat with BSA the controls wells since the coating and blocking buffers have different compositions. Please note that other encephalitogenic peptides (such as PLP139-151 or MBP84-104) could be used as irrelevant antigens in alternative to BSA.
3. The day after, wash the plate 3 times with 200 μL/well of phosphate buffer saline supplemented with 0.05% Tween 20 (PBS-T). Subsequently, add 100 μL/well of a blocking solution made of 3% BSA in PBS (without Tween 20) and incubate the plate sealed for 1 h at 37 °C in a hybridization oven.
4. Wash the plate 3 times with 200 μL/well of PBS-T. Dilute each serum sample 1:100 in blocking solution and add 100 μL/well to both MOG35-55 and BSA coated wells. Add the same volume of blocking solution to the wells designated as blanks. Incubate the plate sealed for 2 h at room temperature, with constant shaking (250 rpm).
5. Wash the plate 3 times with 200 μL/well of PBS-T. Dilute the HRP-conjugated secondary antibody (1:2000, see Table of Materials) in a solution made of 0.2% BSA in PBS-T and add 100 μL/well to all wells. Incubate the plate sealed for 1 h at room temperature, with constant shaking (250 rpm).
6. Wash the plate 3 times with 200 μL/well of PBS-T. Add 100 µL/well of 3,3',5,5' tetramethylbenzidine (TMB) substrate (see Table of Materials) to all the wells and incubate in the dark for 1-5 min, monitoring the development of a blue color.
   1. Stop the reaction by adding 100 µL/well of stop solution (see Table of Materials) and measure the optical density (OD) in each well using a plate reader set at a wavelength of 450 nm.
      ​NOTE: The TMB substrate should be equilibrated at room temperature for 30-60 minutes before adding it to the wells.

3. Data analysis

1. Populate an Excel spreadsheet with the OD values read from the plate. Average the OD values obtained from duplicate wells (both MOG35-55 and BSA coated) for each sample.
2. For each sample, subtract the mean value of the BSA-coated wells from that of MOG35-55 coated wells. The resulting background corrected values will be proportional to the concentration of anti-MOG35-55 antibodies in the different serum samples.
   NOTE: Blank wells should result in corrected values around 0.
3. Apply a non-parametric statistical test such as the Mann-Whitney U test to compare the average OD values between two experimental conditions. Include at least 3 independent samples for each condition.

Results

To demonstrate the robustness of the present ELISA assay, the method was tested on serum samples isolated from a cohort of C57BL/6J female mice at 20 days post-immunization (dpi) with 100 μg of MOG35-55 peptide in complete Freund's adjuvant (CFA) following a validated EAE induction protocol^12,13,14. The animals also received 400 ng of pertussis toxin on day 0 and 2. Serum samples from mock immunized animals with everything but w...

Discussion

Here, a simple and efficient ELISA-based protocol was reported to accurately quantify the humoral response in a relevant animal model of MS pathology. This method has been recently employed to describe the novel role of the ataxin-1 protein in controlling the serum levels of autoantibodies in the MOG35-55/C57BL6J EAE paradigm¹². In this regard, a number of factors should be taken into consideration, in order to obtain consistent and biologically meaningful results with this method.

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
1 mL syringes	BD Biosciences	309628
1.5 mL microcentrifuge tubes	Fisher	05-408-129
25 G needles	BD Biosciences	305122
3,3',5,5'-tetramethylbenzidine (TMB) substrate	Thermo Fisher	N301	Store at 4 °C
Adhesive seals	Thermo Fisher	AB0558
Bovine serum albumin (BSA)	Sigma	A7906	Store at 4 °C
C57BL/6J female mice	The Jackson Laboratory	000664	Animals between 8-10 weeks of age should be used for EAE experiments
Cryogenic tubes	Fisher	10-500-25
Dissection tray	Fisher	S111022
Dissector scissors	Fine Science Tools	14082-09
ELISA coating buffer	BioLegend	421701	Store at 4°C
Excel software	Microsoft		Analysis spreadsheet
Forceps	Fine Science Tools	11152-10
Goat Anti-Mouse IgG, Human ads-HRP	SouthernBiotech	1030-05	Store at 4 °C
LED light source	Fisher	AMPSILED21
Microplate reader	Fisher	14-377-575
Molecular biology grade water	Corning	46-000-Cl
Mouse MOG35-55 peptide	EZBiolab	cp7203	Store at -80 °C
Multichannel pipette	Axygen	AP-12-200-P
Noyes spring scissors	Fine Science Tools	15011-12
Nunc MaxiSorp 96-well plates	BioLegend	423501
Orbital shaker	Fisher	88-861-023
Oven	VWR	445-0024
Phosphate buffer saline (PBS)	Thermo Fisher	14190144
Refrigerated tabletop centrifuge	Thermo Fisher	75002441
Stop solution	Thermo Fisher	N600
Tween 20	Bio-Rad	1706531